DexCom holds the cleaner structural position, with profitability as the main driver and stability adding further support. Boston Scientific still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels.
The comparison is mainly decided in profitability, while stability remains the main counterforce. The overall score gap is 14 points in favour of DexCom, Inc..
Both operate in: Medical Devices
This comparison is based on industry proximity, not on functional trajectory similarity. BSX and DXCM share the same industry classification.
For a similarity-based comparison, see how Boston Scientific and DexCom each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The two profiles are relatively close, but the price setup still leans toward DexCom, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 30-point ROIC advantage.
Stability still tilts materially toward Boston Scientific Corporation, which stops the result from looking dominant across the whole profile.
The profitability lead is clear, but pricing and stability still pull in the other direction — the result holds, but not without friction.
Break down the BSX vs DXCM comparison across all dimensions with the full interactive tool.
Explore how BSX and DXCM each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.